Keynote Speakers

WC9 Plenary speakers (status July 2014)

The following speakers have accepted our invitation:

Czech Republic – Ethics

Marek Vácha Marek Vácha
Head of Department of Ethics
Charles University
Prague, Czech Republic

Animals: Biomechanisms or Evolving Organisms on the Way
to a Reflexive Thought?

Sunday 24 August 2014, 19:00–19:30
Grand Ballroom

Introduction: Dagmar Jirova – WC9 co-chair

 

Drugs & Chemicals

Michel Goldman Michel Goldman
Executive Director
Innovative Medicines Initiative (IMI)
Brussels, Belgium

The rational use of animals in drug development:
contribution of the Innovative Medicines Initiative

Monday 25 August 2014, 9:30–10:00
Congress Hall II

Introduction: Michael Balls – ACT Board

 

EU strategy for 3Rs

Roman Mokrý Roman Mokrý
Policy Officer
DG Health and Consumers of European Commission
Brussels, Belgium

European strategy for 3Rs and replacement of animal experiments
(example of cosmetics sector)

Monday 25 August 2014, 17:15–17:45
Congress Hall II

Introduction: Dagmar Jirova – WC9 co-chair

 

“Human-on-a-chip”

Uwe Marx Uwe Marx
Founder & Chief Scientific Officer
TissUse GmbH
Berlin, Germany

Human-on-a-Chip – a paradigm shift from animal testing

Tuesday 26 August 2014, 9:00–09:30
Congress Hall II

Introduction: Horst Spielmann – ACT Board

 

CROs (Contract Research Organizations)

Nancy Gillett Nancy Gillett
Corporate Executive Vice President & Chief Scientific Officer
Charles River Laboratories
Wilmington, MA, USA

Industrial Perspectives on the 3Rs and Animal Welfare

Tuesday 26 August 2014, 17:15–17:45
Congress Hall II

Introduction: Andrew Rowan – ACT Board

 

Animal Welfare

Roman Kolar Roman Kolar
Deputy Director
Animal Welfare Academy
Neubiberg, Germany

How long must they suffer? Success and failure of our efforts
to end the animal tragedy in laboratories

Wednesday 27 August 2014, 9:00–09:30
Congress Hall II

Introduction: Gilly Griffin – ACT Board

 

Emerging Countries

He Zhengming He Zhengming
Director
National Institutes for Food and Drug Control (NIFDC)
Beijing, China

Future perspectives for alternatives to animal testing in China

Wednesday 27 August 2014, 17:15–17:45
Congress Hall II

Introduction: Herman Koëter – ACT Board

 

US Program “Toxicology in the 21st Century”

Robert J. Kavlock Robert J. Kavlock
Deputy Assistant Administrator for Science
Office of Research and Development
US EPA
Washington DC, USA

Lessons Learned from ToxCast and Prospects for the Future

Thursday 28 August 2014, 9:00–09:30
Congress Hall II

Introduction: Thomas Hartung – ACT Board